Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Wohl

Showing results (41-50 of 185) with videos related to

Pageof 19
Sort By:
AIDS (London, England)|November 6, 2003
Cytomegalovirus-specific IFN-gamma production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapyAdriana Weinberg, David A Wohl, Samantha MaWhinney, et al.
Public Health Reports (Washington, D.C. : 1974)|May 12, 2016
Efforts at the Frontlines: Implementing a Hepatitis C Testing and Linkage-to-Care Program at the Local Public Health LevelArlene C Seña, Sarah J Willis, Alison Hilton, et al.
AIDS and Behavior|January 21, 2019
Underutilization of HIV Testing Among Men with Incarceration HistoriesClaire E Farel, Carol E Golin, Rebecca D Ochtera, et al.
International Journal of Environmental Research and Public Health|May 10, 2019
Estimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United StatesRichard A Elion, Mina Kabiri, Kenneth H Mayer, et al.
Plos One|July 19, 2011
Does HAART efficacy translate to effectiveness? Evidence for a trial effectPrema Menezes, William C Miller, David A Wohl, et al.
Antiviral Therapy|January 17, 2014
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)David A Wohl, Chloe Orkin, Manuela Doroana, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 11, 2019
Reproductive health sequelae among women who survived Ebola virus disease in LiberiaChristine L Godwin, David A Wohl, William A Fischer Nd, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|February 15, 2017
Implementing a Prison Medicaid Enrollment Program for Inmates with a Community Inpatient HospitalizationDavid L Rosen, Catherine A Grodensky, Anna R Miller, et al.
Journal of Health Care for the Poor and Underserved|September 30, 2004
Availability of and access to medical services among HIV-infected inmates incarcerated in North Carolina county jailsDavid L Rosen, Carol E Golin, Victor J Schoenbach, et al.
AIDS and Behavior|April 28, 2017
Estimating HIV Medication Adherence and Persistence: Two Instruments for Clinical and Research UseDavid A Wohl, A T Panter, Christine Kirby, et al.
Pageof 19

Showing results (41-50 of 185) with videos related to

Sort By:
Pageof 19
AIDS (London, England)|November 6, 2003
Cytomegalovirus-specific IFN-gamma production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapyAdriana Weinberg, David A Wohl, Samantha MaWhinney, et al.
Public Health Reports (Washington, D.C. : 1974)|May 12, 2016
Efforts at the Frontlines: Implementing a Hepatitis C Testing and Linkage-to-Care Program at the Local Public Health LevelArlene C Seña, Sarah J Willis, Alison Hilton, et al.
AIDS and Behavior|January 21, 2019
Underutilization of HIV Testing Among Men with Incarceration HistoriesClaire E Farel, Carol E Golin, Rebecca D Ochtera, et al.
International Journal of Environmental Research and Public Health|May 10, 2019
Estimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United StatesRichard A Elion, Mina Kabiri, Kenneth H Mayer, et al.
Plos One|July 19, 2011
Does HAART efficacy translate to effectiveness? Evidence for a trial effectPrema Menezes, William C Miller, David A Wohl, et al.
Antiviral Therapy|January 17, 2014
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)David A Wohl, Chloe Orkin, Manuela Doroana, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 11, 2019
Reproductive health sequelae among women who survived Ebola virus disease in LiberiaChristine L Godwin, David A Wohl, William A Fischer Nd, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|February 15, 2017
Implementing a Prison Medicaid Enrollment Program for Inmates with a Community Inpatient HospitalizationDavid L Rosen, Catherine A Grodensky, Anna R Miller, et al.
Journal of Health Care for the Poor and Underserved|September 30, 2004
Availability of and access to medical services among HIV-infected inmates incarcerated in North Carolina county jailsDavid L Rosen, Carol E Golin, Victor J Schoenbach, et al.
AIDS and Behavior|April 28, 2017
Estimating HIV Medication Adherence and Persistence: Two Instruments for Clinical and Research UseDavid A Wohl, A T Panter, Christine Kirby, et al.
Pageof 19